Protein binding characteristics of new bronchodilators, 1-methyl-3-propylxanthine (MPX) and 3-propylxanthine (enprofylline)
- 1 December 1989
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 56 (3) , 235-241
- https://doi.org/10.1016/0378-5173(89)90020-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Studies on Alkyl-Xanthine Derivatives II. Pharmacokinetic and Pharmacodynamic Studies of a New Bronchodilator, 1-Methyl-3-Propylxanthine (MPX)The Japanese Journal of Pharmacology, 1988
- Structure-activity relationship in N3-alkyl-xanthine derivatives.The Japanese Journal of Pharmacology, 1988
- Plasma protein binding—lipophilicity relationships: interspecies comparison of some organic acidsJournal of Pharmacy and Pharmacology, 1987
- Free and total plasma theophylline concentrations in chronic airflow obstruction.Thorax, 1984
- Intravenous administration of enprofylline to asthmatic patientsEuropean Journal of Clinical Pharmacology, 1983
- Enprofylline - Effects of a New Bronchodilating Xanthine Derivative in Asthmatic PatientsAllergy, 1983
- A pharmacokinetic analysis program (multi) for microcomputer.Journal of Pharmacobio-Dynamics, 1981
- Absence of effect of heparin on the binding of prazosin and phenytoin to plasma proteinsBiochemical Pharmacology, 1980
- Pharmacokinetic analysis of the effect of the ophylline on pulmonary function in asthmatic childrenThe Journal of Pediatrics, 1975
- INFLUENCE OF FREE FATTY ACID CONCENTRATION ON DRUG BINDING TO PLASMA ALBUMIN*Annals of the New York Academy of Sciences, 1973